| SN. |
Smith & Nephew
|
FTSE 100 |
2.44 |
£9.99B |
1,158.50 |
-2.48% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.40 |
£4.47B |
224.00 |
-2.10% |
| UPR |
Uniphar
|
AIM |
0.46 |
£942.76M |
366.00 |
0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.02 |
£607.03M |
280.00 |
3.10% |
| NIOX |
Niox Group
|
AIM |
2.57 |
£254.1M |
60.40 |
% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£110.64M |
25.50 |
1.00% |
| SPEC |
Inspecs Group
|
AIM |
|
£98.62M |
99.00 |
-0.30% |
| SDI |
SDI Group
|
AIM |
|
£95.14M |
91.60 |
-1.50% |
| CREO |
Creo Medical Group
|
AIM |
|
£59.51M |
13.06 |
-0.80% |
| KMK |
Kromek Group
|
AIM |
|
£48.48M |
7.40 |
8.70% |
| NCYT |
Novacyt SA
|
AIM |
|
£26.43M |
36.60 |
4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£16.59M |
18.35 |
0.60% |
| RUA |
RUA Life Sciences
|
AIM |
|
£14.89M |
24.16 |
-6.90% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.66M |
0.50 |
-2.30% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£2.18M |
0.46 |
-3.80% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |